Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


U.S. Patent and Trademark Office Issues Patent 8,212,658, Fifth in Portfolio Protecting Technology to Advance Medication Management
New Directions Technology Consulting, LLC, Is Exclusive mHealth-Market Developer for the mMed Patent Portfolio for Mobile Medication Management

HUNTINGTON, NY -- (Marketwire) -- 11/29/12 -- U.S. Patent 8,212,658, the fifth in a portfolio of patents protecting technology that could significantly advance medication management, has been issued by the USPTO. New Directions Technology Consulting, LLC (New Directions) is the exclusive market developer of the intellectual property.

New Directions Managing Director Napoleon Monroe, the inventor on all patents in what is called the mMed portfolio for mobile medication management, brings his decades of experience in manufacturing, licensing, regulatory process and risk management to the effort.

"Optimum management of chronic and acute health problems that require medication therapy depends on patients following instructions for treatment prescribed by medical professionals -- what's called 'adherence,'" said Monroe. "But patient nonadherence impedes wellness and drives up to $300 billion of avoidable U.S. healthcare costs, with costs of related lost productivity arguably even greater."

Monroe continued: "As the world's mobile-communications user community grows, new 'smart' tools, such as in the patent claims, can be developed to help patients themselves successfully manage medication therapies outside institutional settings."

He noted that advanced mobile medication management systems using technology protected by the mMed patent portfolio could include:

  • medication delivery devices or containers with embedded sensors
  • communication devices with cameras, microphones, third-party applications, and short- and long-range communication capabilities to deliver data to patients, caregivers and medical professionals at a central monitoring facility

Such systems could not only give "a critical boost to medication adherence," but also could provide "additional benefits to all stakeholders" in the healthcare supply chain: patients, caregivers, employers, insurers, government and taxpayers, said Monroe. When at Survival Technology (now part of Pfizer), Monroe invented three medical devices that were patented and commercialized, and led teams that invented, prototyped, tested, commercialized and/or scaled up such products as the EpiPen and the Antidote Treatment Nerve Agent Auto-Injector delivery system.

In addition to providing reminders and facilitating the replenishment process, systems based on technology protected by the mMed patent portfolio could do much more, Monroe said, including:

  • automate identification of patient and the medication in patient's hands;
  • verify dosing;
  • relate quantity of medication available;
  • provide medication-condition alerts (e.g., premature degradation, breakage);
  • inform re drug interactions, adverse drug reactions, abuse;
  • instruct for proper use and disposal;
  • integrate real-time medication usage data into medical records;
  • deliver information to medical professionals in a central monitoring facility; and
  • facilitate communication with and support among healthcare professionals.

mMed Patent Portfolio
Monroe noted that one additional U.S. and foreign patents are pending. He added that global healthcare distribution and service company Henry Schein, Inc., where he had been vice president for private-label activities, is the assignee of the patents in the portfolio.

Through New Directions, business opportunities related to the mMed patent portfolio include: licensing of patents or the entire portfolio, licensing for specific disease conditions or geographies, or partnering to develop tools, platforms or systems based on the patents. The U.S. portfolio of granted patents includes:

U.S. Patent No. 7,752,085 (issued 7/6/2010): Product Information Management System
U.S. Patent 7,871,393 (issued 1/18/2011): Injection Device and Case with Reporting Ability: Covers means for showing that a drug containing injector is not being carried by the assigned person by comparing two location reports.
U.S. Patent 8,044,778 (issued 10/25/2011): Injection Device and Case with Reporting Ability: Covers means for including one or multiple medications and dosage forms in cases and communicating added information.
U.S. Patent 8,149,111 (issued 4/3/2012): Central Facility that Communicates with Portable Container via Mobile Device
U.S. Patent 8,212, 658 (issued 7/3/2012): Product Container for Use with Device Capable of Long-Range and Short-Range Communications

Monroe said: "Greater patient autonomy through technology can result in better health outcomes and reduced costs. Providing medication management tools to patients also presents tremendous business opportunities for those at the forefront of the evolving mHealth industry."

About New Directions Technology Consulting, LLC
New Directions Technology Consulting develops commercial opportunities for its clients, primarily in areas of healthcare. The firm's focus is on medication management; telemedicine; advanced drug-delivery systems; and healthcare products information management, including track-and-trace labeling, quality systems and product standards.

For more information about the mMed patent portfolio, please go to www.mmedhealth.com.

Note: mMed is a trademark of New Directions Technology Consulting, LLC. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2167245

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Rick Sacks
Email Contact
973.467.8728

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
Despite the data privacy protections supposedly conferred by regulations like HIPAA and HITECH, consumers’ confidential health and personal information is still not safe enough. That’s the lesson to be learned from Franklin, TN-based Community Health Systems’ (CHS) August 18 regulatory...
Putting on a rock show is like piloting the Millenium Falcon – it’s simultaneously the fastest ship in the galaxy while being a “piece of junk.” The stage lights are so hot you start to sweat immediately, hoping those Jager-bombs are escaping through your pores and delaying the impend...
The IT infrastructure of modern businesses require a number of seemingly never-ending cycles to track assets. As these assets go through different stages of usefulness or functionality, IT teams must constantly manage the process, which takes them away from other more important tasks a...
The Open Group and BriefingsDirect recently assembled a distinguished panel at The Open Group Boston Conference 2014 to explore the practical implications and limits of the Internet of Things. This so-called Internet of Things means more data, more cloud connectivity and management, a...
General Electric (GE) has been a household name for more than a century, thanks in large part to its role in making households easier to run. Starting with the light bulb invented by its founder, Thomas Edison, GE has been selling devices (“things”) to consumers throughout its 122-year...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE